| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |